HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Results of noncurative resection of primary lung cancer].

Abstract
Out of 1099 cases of primary lung cancer patients who underwent surgical treatment in our department from 1952 to 1988, 374 cases were divided as noncurative by the post surgical examination. We divided the causes of noncurative resection as follows; I) absolute noncurative resection 1) tumor rest in a) lymph nodes (Ly rest), b) chest wall or diaphragma (Ch + Dia rest), c) bronchial stump (Bro rest) 2) intra-pulmonary metastasis (pm), 3) dissemination or pleuritis carcinomatosa (Dis + pl) II) relative noncurative 1) incomplete dissection of lymph nodes (Ro) 2) group 2b lymph node metastasis (2b Ly). Ly rest was the commonnest (103 cases 27.5%) in noncurative resection and Ch + Dia rest (94 cases, 25.1%) and p.m. (54 cases 14.4%) followed thereafter. Two thirds of the noncurative cases were classified into these 3 groups, and the rest of the causes were Dis + pl, Bro rest. RO and 2b Ly groups. p.m. and Ly rest groups were the most common causes of noncurative resection in adenocarcinoma cases whereas Ly rest and Ch + Dia rest groups were common in squamous cell carcinoma cases. Five year survival rate of the total noncurative cases was 12.1% although those of Dis + pl groups was 22.9% and those of p.m. group was 18.8%. Five year survival rate of the other groups were around 10%. A slightly better survival rate was observed when relative noncurative resection was performed in RO (19.7%) and 2b Ly (18.7%) groups.
AuthorsH Kimura, Y Yamaguchi, T Fujisawa, M Shiba, H Saitoh, H Yamakawa, N Iwai, K Shibuya, M Fujino, Y Sekine
Journal[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai (Nihon Kyobu Geka Gakkai Zasshi) Vol. 39 Issue 3 Pg. 257-61 (Mar 1991) ISSN: 0369-4739 [Print] Japan
PMID2051081 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Female
  • Humans
  • Lung Neoplasms (mortality, pathology, surgery)
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Prognosis
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: